Curis
CRIS
#10335
Rank
โ‚น1.80 B
Marketcap
โ‚น46.24
Share price
-2.08%
Change (1 day)
-73.96%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -โ‚น2.82 Billion

According to Curis's latest financial reports the company's current earnings are โ‚น11.65 Million. In 2024 the company made an earning of -โ‚น4.13 Billion, an increase over its 2023 earnings that were of -โ‚น4.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.82 Billion-31.8%
2024 -โ‚น4.13 Billion-5.77%
2023 -โ‚น4.38 Billion-13.1%
2022 -โ‚น5.04 Billion27.52%
2021 -โ‚น3.95 Billion65.09%
2020 -โ‚น2.4 Billion-9.1%
2019 -โ‚น2.63 Billion-4.73%
2018 -โ‚น2.76 Billion-41.95%
2017 -โ‚น4.76 Billion-14.37%
2016 -โ‚น5.56 Billion3.55%
2015 -โ‚น5.37 Billion271.52%
2014 -โ‚น1.45 Billion76.64%
2013 -โ‚น0.82 Billion
2011 -โ‚น0.7 Billion27.76%
2010 -โ‚น0.55 Billion-43.87%
2009 -โ‚น0.97 Billion-23.44%
2008 -โ‚น1.27 Billion56.66%
2007 -โ‚น0.81 Billion-16.71%
2006 -โ‚น0.97 Billion-36.92%
2005 -โ‚น1.54 Billion156.25%
2004 -โ‚น0.6 Billion-37.24%
2003 -โ‚น0.96 Billion-93.34%
2002 -โ‚น14.34 Billion86.79%
2001 -โ‚น7.68 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.020 T-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น924.52 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น5.97 Billion 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น96.64 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น27.69 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น2.39 Billion-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น15.92 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA